Inventor
ANLAUF SONJA
DE17 patents
⚠️ This page may combine multiple inventors who share the name “ANLAUF SONJA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VON NUSSBAUM FRANZ
5 patentsUS8889700B2Nov 18, 2014
4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
VON NUSSBAUM FRANZ19 citations91
US8288402B2Oct 16, 2012
4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
VON NUSSBAUM FRANZ9 citations83
US8691817B2Apr 8, 2014
Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
VON NUSSBAUM FRANZ6 citations72
US8569314B2Oct 29, 2013
Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD
VON NUSSBAUM FRANZ4 citations62
US8076285B2Dec 13, 2011
Lysobactin amides
VON NUSSBAUM FRANZ0 citations39
AICURIS GMBH & CO KG
5 patentsUS7531507B2May 12, 2009
Acylated nonadepsipeptides containing pyridyl alanine residues
AICURIS GMBH & CO KG11 citations82
US7368424B2May 6, 2008
Acylated nonadepsipeptides
AICURIS GMBH & CO KG11 citations82
US7727956B2Jun 1, 2010
Deoxonadepsipeptides
AICURIS GMBH & CO KG1 citations50
US7786079B2Aug 31, 2010
Substituted nonadepsipeptides
AICURIS GMBH & CO KG0 citations40
US7718611B2May 18, 2010
Cyclic nonapeptide amides
AICURIS GMBH & CO KG0 citations40
Bayer Pharma AG
4 patentsUS9957235B2May 1, 2018
Benzimidazol-2-amines as mIDH1 inhibitors
Bayer Pharma AG8 citations83
US9951027B2Apr 24, 2018
Benzimidazol-2-amines as MIDH1 inhibitors
Bayer Pharma AG8 citations83
US10137110B2Nov 27, 2018
1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors
Bayer Pharma AG4 citations70
US10442772B2Oct 15, 2019
Benzimidazol-2-amines as mIDH1 inhibitors
Bayer Pharma AG0 citations51